Companies gaining market access for Medical Cannabis in Germany and other European countries are confronted with complex and differing national requirements. From cultivation to distribution of medical cannabis, all activities are legally linked to individual national laws under control of the individual European countries. The EU is missing a harmonized law on medical and recreational use of cannabis. This webinar gives a general overview on the legislation in different European countries reflecting different kind of programs for patient´s access to medicinal Cannabis.
Key learning objectives:
- Basis of Legislation for global control on Narcotic Drugs
- Basis of different European national legislation on medicinal cannabis and CBD
- Categorization of Cannabis flos and Cannabis derived products
- Requirements for the pharmaceutical entrepreneur for marketing Cannabis derived products
- Different European strategies on availability of Medical Cannabis for Patients
- Upcoming trends
